Provider and patient characteristics associated with antidepressant nonadherence: The impact of provider specialty

Journal of Clinical Psychiatry

Volumn 68, Issue 6, 2007, Pages 867-873

  Bambauer, Kara Zivin ^a,b,c   Soumerai, Stephen B ^a   Adams, Alyce S ^a   Zhang, Fang ^a   Ross Degnan, Dennis ^a  

^a HARVARD PILGRIM HEALTH CARE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CHRONIC DISEASE; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIST; TREATMENT OUTCOME;

EID: 34347351927     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v68n0607     Document Type: Article

References (43)

1. Katon W, Sullivan MD. Depression and chronic medical illness. J Clin Psychiatry 1990;51(6, suppl):3-11; discussion 12-14
2. Tierney R, Melfi CA, Signa W, et al. Antidepressant use and use patterns in naturalistic settings. Drug Benefit Trends 2000;12:7-12
3. Hansen DG, Vach W, Rosholm JU, et al. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract 2004;21:623-629
4. Bull SA, Hu XH, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. JAMA 2002;288:1403-1409
5. National Committee for Quality Assurance. Antidepressant Medication Management (effective continuation phase treatment): Percentage of Members Who Remained on an Antidepressant Drug for at Least 180 Days (six months). Health Plan Employer Data and Information Set (HEDIS) 2004: Technical Specifications, vol 2. Washington, DC: National Committee for Quality Assurance (NCQA); 2003
6. Melfi CA, Chawla AJ, Croghan TW, et al. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998;55:1128-1132
7. Sood N, Treglia M, Obenchain RL, et al. Determinants of antidepressant treatment outcome. Am J Manag Care 2000;6:1327-1336
8. Thase ME. The clinical, psychosocial, and pharmacoeconomic ramifications of remission. Am J Manag Care 2001;7(suppl 11):S377-S385
9. Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance treatment of recurrent unipolar major depression. Biol Psychiatry 1998;44:348-360
10. Katon W, Von Korff M, Lin E, et al. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry 1999;56:1109-1115
11. Simon GE, Katon W, Rutter C, et al. Impact of improved depression treatment in primary care on daily functioning and disability. Psychol Med 1998;28:693-701
12. Robinson RL, Long SR, Chang S, et al. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims. J Manag Care Pharm 2006;12:43-54
13. Lewis E, Marcus SC, Olfson M, et al. Patients' early discontinuation of antidepressant prescriptions. Psychiatr Serv 2004;55:494
14. Dobrez DG, Melfi CA, Croghan TW, et al. Antidepressant treatment for depression: total charges and therapy duration. J Ment Health Policy Econ 2000;3:187-197
15. Lin EH, Katon WJ, Simon GE, et al. Low-intensity treatment of depression in primary care: is it problematic? Gen Hosp Psychiatry 2000;22:78-83
16. Vermeire E, Hearnshaw H, Van Royen P, et al. Patient adherence to treatment: three decades of research: a comprehensive review. J Clin Pharm Ther 2001;26:331-342
17. Clinical Practice Guideline Number 5: Depression in Primary Care, vol 2. Treatment of Major Depression. Rockville, Md: US Dept Health Human Services, Agency for Health Care Policy and Research; 1993. AHCPR publication 93-0551
18. National Committee for Quality Assurance. Antidepressant Medication Management (optimal practitioner contacts for medication management): Percentage of Members Who Had Three or More Outpatient Follow-Up Visits or Day/Night Treatment With a Non-Mental Health Practitioner or Mental Health Practitioner Within 84 Days (12 weeks) After New Diagnosis of Depression. Washington, DC: National Committee for Quality Assurance (NCQA); 2003
19. Busch SH, Leslie D, Rosenheck R. Measuring quality of pharmacotherapy for depression in a national health care system. Med Care 2004; 42:532-542
20. Bambauer KZ, Soumerai SB, Adams AS, et al. Does antidepressant adherence have an effect on glycemic control among diabetic antidepressant users? Int J Psychiatry Med 2004;34:291-304
21. Clark DO, Von Korff M, Saunders K, et al. A chronic disease score with empirically derived weights. Med Care 1995;33:783-795
22. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22
23. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986;42:121-130
24. Demyttenaere K, Enzlin P, Dewe W, et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 2001;62(suppl 22):30-33
25. Kniesner TJ, Powers RH, Croghan TW. Provider type and depression treatment adequacy. Health Policy 2005;72:321-322
26. Stewart AL, Sherbourne CD, Wells KB, et al. Do depressed patients in different treatment settings have different levels of well-being and functioning? J Consult Clin Psychol 1993;61:849-857
27. Campbell LC, Clauw DJ, Keefe FJ. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry 2003;54:399-409
28. Von Korff M, Simon G. The relationship between pain and depression. Br J Psychiatry Suppl 1996;30:101-108
29. Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433-2445
30. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA 1995;273:1026-1031
31. Valenstein M, Klinkman M, Becker S, et al. Concurrent treatment of patients with depression in the community: provider practices, attitudes, and barriers to collaboration. J Fam Pract 1999;48:180-187
32. Aikens JE, Nease DE Jr, Nau DP, et al. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 2005;3:23-30
33. Croghan TW, Melfi CA, Dobrez DG, et al. Effect of mental health specialty care on antidepressant length of therapy. Med Care 1999;37 (suppl 4):AS20-AS23
34. Van Voorhees BW, Cooper LA, Rost KM, et al. Primary care patients with depression are less accepting of treatment than those seen by mental health specialists. J Gen Intern Med 2003;18:991-1000
35. Lewis CL, Wickstrom GC, Kolar MM, et al. Patient preferences for care by general internists and specialists in the ambulatory setting. J Gen Intern Med 2000;15:75-83
36. Donoghue J, Hylan TR. Antidepressant use in clinical practice: efficacy v effectiveness. Br J Psychiatry Suppl 2001;42:S9-S17
37. Fairman KA, Teitelbaum F, Drevets WC, et al. Course of antidepressant treatment with tricyclic versus selective serotonin reuptake inhibitor agents: a comparison in managed care and fee-for-service environments. Am J Manag Care 1997;3:453-465
38. Bambauer KZ, Adams AS, Zhang F, et al. Physician alerts to increase antidepressant adherence: fax or fiction? Arch Intern Med 2006;166: 498-504
39. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-116
40. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37:846-857
41. Bieszk N, Patel R, Heaberlin A, et al. Detection of medication non-adherence through review of pharmacy claims data. Am J Health Syst Pharm 2003;60:360-366
42. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005;11:449-457
43. Masand PS. Tolerability and adherence issues in antidepressant therapy. Clin Ther 2003;25:2289-2304